Show simple item record

Effects of ceramide analogs on myelinating organ cultures

dc.contributor.authorBenjamins, Joyce A.en_US
dc.contributor.authorFitch, Johnen_US
dc.contributor.authorRadin, Norman S.en_US
dc.date.accessioned2006-04-07T16:30:25Z
dc.date.available2006-04-07T16:30:25Z
dc.date.issued1976-02-06en_US
dc.identifier.citationBenjamins, Joyce A., Fitch, John, Radin, Norman S. (1976/02/06)."Effects of ceramide analogs on myelinating organ cultures." Brain Research 102(2): 267-281. <http://hdl.handle.net/2027.42/21824>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6SYR-484B368-2VM/2/f0e16cb0a67b89cdb1a695aec0a1ea10en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/21824
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=942878&dopt=citationen_US
dc.description.abstractAnalogs of ceramide which inhibit galactocerebrosidase also demyelinate or inhibit myelination in organ cultures of rat cerebellum. The potency of the analogs in culture correlated with their effectiveness as inhibitors of cerebrosidase, but not with their effectiveness as inhibitors of galactosyl transferase. The most effective compound was the decanoyl amide of 3-phenyl-2-amino-1,3-propanediol with erythro-conformation. Stimulators of cerebrosidase also demyelinated cultures. With both groups of compounds, myelin sheats became distorted, then broke into lipid droplets. Axons were preserved, but neurons showed some nuclear changes and granularity. Metabolic studies with the most effective inhibitor showed that glucose incorporation into cerebroside and other alkali-stable lipids was initially depressed compared to proteins and total lipids.en_US
dc.format.extent1109976 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleEffects of ceramide analogs on myelinating organ culturesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMental Health Research Institute and Department of Biological Chemistry, University of Michigan, Ann Arbor, Mich. 48104, U.S.A.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Md. 21205, USAen_US
dc.contributor.affiliationumMental Health Research Institute and Department of Biological Chemistry, University of Michigan, Ann Arbor, Mich. 48104, U.S.A.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Md. 21205, USAen_US
dc.contributor.affiliationumMental Health Research Institute and Department of Biological Chemistry, University of Michigan, Ann Arbor, Mich. 48104, U.S.A.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Md. 21205, USAen_US
dc.identifier.pmid942878en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/21824/1/0000225.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0006-8993(76)90882-9en_US
dc.identifier.sourceBrain Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.